68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients
Radiotherapy is the main therapeutic approach besides surgery of localized prostate cancer. It relies on risk stratification and exact staging. This report analyses the potential of [68Ga]Glu-urea-Lys(Ahx)-HBED-CC (68Ga-PSMA-11), a new positron emission tomography (PET) tracer targeting prostate-spe...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2016
|
| In: |
European journal of nuclear medicine and molecular imaging
Year: 2015, Volume: 43, Issue: 1, Pages: 34-41 |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-015-3188-1 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00259-015-3188-1 |
| Author Notes: | Florian Sterzing, Clemens Kratochwil, Hannah Fiedler, Sonja Katayama, Gregor Habl, Klaus Kopka, Ali Afshar-Oromieh, Jürgen Debus, Uwe Haberkorn, Frederik L. Giesel |
Search Result 1
68Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer: a modified protocol compared with the common protocol
Article (Journal)
Online Resource
Search Result 2